Alpha Teknova, Inc. reported $44M of revenue over the trailing twelve months, +12% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $44M (to Q2 2026). Net income: −$17M, trailing twelve months to Q2 2026. Free cash flow: −$7.4M, trailing twelve months to Q2 2026. Operating margin: −37%, trailing twelve months to Q2 2026.

TKNOAlpha Teknova, Inc.

Healthcare

$8.45+61% 1Y

$8.45

$1.9952 weeks$9.34

TKNO as reported

Alpha Teknova, Inc. reported $44M of revenue over the trailing twelve months, +12% on the year before. 10 reported series are charted on this page, each one as filed.

$44M

Revenue, trailing twelve months · to Q2 2026 · +12% against the twelve months before

Net income: −$17M
Net income · −22% year on year · trailing twelve months to Q2 2026
Free cash flow: −$7.4M
Free cash flow · −30% year on year · trailing twelve months to Q2 2026
Operating margin: −37%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for TKNO, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$44M	+12%	Q2 2026
Net income	−$17M	−22%	Q2 2026
EPS	−$0.31	−24%	Q2 2026
Gross margin	34%	n/a	Q2 2026
Operating margin	−37%	n/a	Q2 2026
Net margin	−39%	n/a	Q2 2026
ROE	−26%	n/a	Q2 2026
ROA	−17%	n/a	Q2 2026
ROIC	−22%	n/a	Q2 2026
Free cash flow	−$7.4M	−30%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.